Live immunotherapy News

Live immunotherapy news coverage of developments with the latest updates. Stay on top of latest immunotherapy news stories and find out what just happened, what is going on with immunotherapy. The latest real-time news updates and headlines on immunotherapy
MD Anderson research highlights for December 6, 2021
New immunotherapy for leukemia discovered
AstraZeneca reinforces leadership in breast cancer at SABCS 2021 with new data underscoring ambition to redefine cancer care
New Insights into T-Cell Exhaustion Could Improve Cancer Immunotherapies, Penn Study Finds
NIH scientists discover new B cell that tempers autoimmunity
Activating immune cells for cancer nano-immunotherapy
QIMR Berghofer signs licensing, research and manufacturing deal for new cellular immunotherapy with US company Cellevolve Bio
Study Finds Sequencing Bone Marrow DNA after CAR-T Can Accurately and Sensitively Predict Leukemia Relapse
Potential new treatment for Alzheimer’s disease would be relatively cheap
Exhaustion affects CAR T-cell clinical response
New review highlights cancer-crushing viruses
New Collaborative Research Center with participation from Johannes Gutenberg University Mainz
Gut medication hindering lung cancer treatment
Antihistamines can influence immunotherapy response by enhancing T cell activation
Common medication hindering lung cancer treatment
Health research boosted with $1.45 million to fund fellowships
Baylor, TCH and ImmunityBio collaborate for Covid vaccine for Africa
UvA honorary doctorates for vaccine developers Ugur Sahin and Özlem Türeci
Stealthy way to combat tumors
Breaking down cancer’s defenses
Discovery of how immune cells sense nutrients offers new therapeutic insight
Strategy to overcome tumors’ resistance to immunotherapy generates promising clinical trial results
Dana-Farber research supports FDA approval of immunotherapy drug given after surgery for certain patients with kidney cancer
KU Leuven develops an assay for patient-specific monitoring and treatment for ovarian cancer
Target prevents T-cell exhaustion, boosts CAR T-cell responses
Fasting-mimicking diet is safe, may modulate metabolism and boost antitumor immunity in cancer patients
New childhood brain centre brings fresh hope to families
Leading fight against childhood brain cancer
Practice-changing trial results for advanced melanoma skin cancer
Scientists make strides toward an ‘off-the-shelf’ immune cell therapy for cancer
Ludwig Lausanne team devises method to selectively grow tumor-targeting T cells for cancer therapy
Using T cells to target malignant brain tumors
Research points to new method to improve ovarian cancer treatment
Nanoparticle T cell engagers for treatment of acute myeloid leukemia
100 years of insulin: How immunotherapy could be future of diabetes treatment
Research reveals metformin-dependent antitumor immunity
New technique may lead to safer stem cell transplants
Combination immunotherapy improves survival for patients with asymptomatic melanoma brain metastases
Second wave of kids with MIS-C had more severe illness than first wave, according to new Children’s National Hospital study
Collaboration on Data and Computational Sciences Announces Next Round of Projects to Advance Cancer Breakthroughs
Reversing new-onset type 1 diabetes with pyramid-like DNA
Immunotherapy may yield longer treatment-free survival than targeted therapy
Model predicts early response to cancer immunotherapy
Hyperprogression of mismatch repair-deficient colon cancer
First for Switzerland: proton therapy to treat lung cancer
UVA Awards $19M in STEM Funding to 4 Key Research Projects
Nature Medicine publishes phase 2 trial data showing durvalumab immunotherapy with standard chemotherapy improved survival
Science and pseudoscience of food allergy and intolerance testing